Motoric cognitive risk (MCR) syndrome signals dementia risk in older adults, with social relationships recognized as modifiable influences; however, their interconnectedness with the multilayer factors of the health ecology model remains underexplored. This study aims to investigate the central and bridgin...
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
Most studies assessing the effect of central nervous system (CNS)-acting medicines on cognitive disturbances have focused on the use of individual medicines. The impact on cognitive function when another CNS-acting medicine is added to a patient's treatment regimen is not well known.
To investigate the associations between central anticholinergic burden and mortality, hospitalization, and cognitive impairment in people with dementia prescribed anticholinergic drugs for urinary symptoms.
Are you ready to take your career as a medical director to new heights? Elevate your professional standing and demonstrate your comprehensive understanding of the role by becoming a Certified Medical Director (CMD). This prestigious certification not only showcases your expertise and dedication but also op...